MENU

PLX Protalix BioTherapeutics Forecast, Technical & Fundamental Analysis

a developer of recombinant therapeutic proteins

Industry Biotechnology
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PLX is expected to report earnings to rise 233.33% to 10 cents per share on March 13

Protalix BioTherapeutics PLX Stock Earnings Reports
Q4'24
Est.
$0.10
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.04
Q4'23
Est.
$-0.03
The last earnings report on November 14 showed earnings per share of 2 cents, missing the estimate of 5 cents. With 119.65K shares outstanding, the current market capitalization sits at 128.12M.
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

PLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with PCVX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-0.57%
PCVX - PLX
33%
Loosely correlated
+0.41%
NTLA - PLX
32%
Poorly correlated
-1.87%
SRRK - PLX
32%
Poorly correlated
+1.82%
BEAM - PLX
31%
Poorly correlated
-1.21%
PRME - PLX
31%
Poorly correlated
-3.00%
More